Product Description

Can Psychedelics do for psychiatry what the microscope did for biology and the telescope to astronomy? Can they be used to access on the depths of the psyche that are usually inaccessible? Psychedelic means: mind manifesting Psychedelics were inextricably associated with the hippie counterculture of the 1960s and, more recently, with the rave music scene and were once believed to hold great promise for treating a number of medical conditions as well as providing access to profound spiritual experiences. However, legal restrictions on the use of such drugs effectively forced them underground and brought clinical research to a halt until recently. In this book, psychiatrist Dr. Ben Sessa makes a persuasive case for the re-evaluation of psychedelics LSD, MDMA (Ecstasy), DMT, psilocybin, ayahuasca, peyote, ibogaine, and more as he explores their clinical potential for treating a range of conditions from post-traumatic stress disorder and depression to autism and cluster headaches. Based on a thorough review of the evidence Sessa corrects some common misconceptions about psychedelics and makes a clarion call for their responsible therapeutic use, with appropriate set and setting, in psychotherapy, psychiatry and personal growth. Topics covered in this book include: What are the drugs and why are they so controversial? How should they be safely and wisely used What is the nature of the psychedelic experience? What are the implications for psychiatry and for psycho spiritual growth? With clarity and wit, the author surveys the contributions of major figures in the psychedelic movement from Huxley, Hofmann and Sandison to Leary, Grof and McKenna and takes the reader on a journey through the fascinating history of psychedelic plants and chemicals as he considers the crucial role such drugs have had in human culture from prehistory to modern times. Enter the shamans of science and the psychonauts of psychiatry Although books on psychedelics abound, volumes like The Psychedelic Renaissance show how the field is now addressing the substance of findings from recent research rather than the legions of case reports and anecdotes. Kelly Morris The Lancet Vol. 381 February16, 2013 --The Lancet Vol. 381